World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
24564
World Ranking
17494
National Ranking
8758

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Christopher P. Evans is affiliated with the University of California, Davis in the United States. Their research primarily focuses on fields related to Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in subfields such as Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology, and Radiology, Nuclear Medicine and Imaging.

The scientist has authored numerous publications in high-impact venues. Frequent publication venues include:

  • Journal of Clinical Oncology
  • Cancer Research
  • European Urology
  • The Journal of Urology
  • Molecular Cancer Therapeutics

Christopher P. Evans's research covers a variety of main topics including:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism
  • Cancer-related gene regulation
  • Cancer Immunotherapy and Biomarkers
  • Radiopharmaceutical Chemistry and Applications
  • PARP inhibition in cancer therapy

Among recent papers, notable works include:

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 (2020, European Urology)
  • The DNA methylation landscape of advanced prostate cancer (2020, Nature Genetics)
  • Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance (2020, Proceedings of the National Academy of Sciences)
  • Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 (2023, European Journal of Cancer)
  • Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial (2021, Circulation)

Frequent co-authors contributing alongside Christopher P. Evans include:

  • Martin Gleave
  • Allen C. Gao
  • Felix Y. Feng
  • Eric J. Small
  • Shu Ning

The scientist has been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    Tomasz M Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Human polymorphism at microRNAs and microRNA target sites.

    Liuqing Yang;Chunru Lin;Chunyu Jin;Joy C. Yang

  • lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs

    Liuqing Yang;Chunru Lin;Chunru Lin;Chunyu Jin;Joy C. Yang

  • Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

    David A. Quigley;Ha X. Dang;Shuang G. Zhao;Paul Lloyd

  • Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

    Rahul Aggarwal;Jiaoti Huang;Joshi J. Alumkal;Li Zhang

  • An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells.

    Xu Bao Shi;Lingru Xue;Joy Yang;Ai Hong Ma

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Mechanisms of resistance in castration-resistant prostate cancer (CRPC)

    Thenappan Chandrasekar;Joy C. Yang;Allen C. Gao;Christopher P. Evans

  • MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

    James W F Catto;Antonio Alcaraz;Anders S. Bjartell;Ralph W deVere White

  • Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.

    Tomasz M. Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer

    Alexander W Wyatt;Matti Annala;Rahul Aggarwal;Kevin Beja

  • Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer

    Chengfei Liu;Wei Lou;Yezi Zhu;Nagalakshmi Nadiminty

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented]

    Silke Gillessen;Gerhardt Attard;Tomasz M. Beer;Himisha Beltran

  • Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.

    Theodoros Karantanos;Christopher P. Evans;Bertrand Tombal;Timothy C. Thompson

  • The DNA methylation landscape of advanced prostate cancer

    Shuang G. Zhao;Shuang G. Zhao;William S. Chen;William S. Chen;Haolong Li;Adam Foye

  • Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer

    Chengfei Liu;Wei Lou;Yezi Zhu;Joy C. Yang

  • Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK

    Li Fen Lee;Maggie C. Louie;Sonal J. Desai;Joy Yang

  • Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage.

    Kirk A. Keegan;Clayton W. Schupp;Karim Chamie;Nicholas J. Hellenthal

  • Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.

    Nicholas J. Hellenthal;Shahrokh F. Shariat;Vitaly Margulis;Pierre I. Karakiewicz

  • Genomic Markers in Prostate Cancer Decision Making

    Vito Cucchiara;Matthew R. Cooperberg;Marc Dall’Era;Daniel W. Lin

Frequent Co-Authors

Primo N. Lara
Primo N. Lara University of California, Davis
Hsing Jien Kung
Hsing Jien Kung Taipei Medical University
Tomasz M. Beer
Tomasz M. Beer Oregon Health & Science University
Martin E. Gleave
Martin E. Gleave University of British Columbia
Eric J. Small
Eric J. Small University of California, San Francisco
Robert E. Reiter
Robert E. Reiter University of California, Los Angeles
Kim N. Chi
Kim N. Chi BC Cancer Agency
George Thomas
George Thomas Oregon Health & Science University
Jiaoti Huang
Jiaoti Huang Duke University
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine can open the door to numerous related online degrees and career pathways. Healthcare administration is a fast-growing field, and prospective students often wonder which online healthcare administration programs have cahme accreditation? Accreditation is vital to ensure your degree is recognized and meets industry standards.

For practicing nurses seeking to advance their credentials, online RN to BSN programs can be a flexible option. Many learners are interested in rn to bsn no clinical hours options, which allow for career progression without the additional burden of in-person clinical requirements.

Those aiming for leadership roles or advanced practice may benefit from accelerated Doctor of Nursing Practice (DNP) programs. If speed is a priority, explore accelerated dnp programs to complete your degree in less time. Budget-conscious students may also be interested in the cheapest dnp program to reduce tuition costs while still earning a valuable credential.

By understanding these options, you can better align your education and career trajectory in the dynamic field of medicine and healthcare.

Best Scientists Citing Christopher P. Evans

Trending Scientists